These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7968797)
1. Neurourologic consequences of accidental intrathecal vincristine: a case report. Zaragoza MR; Ritchey ML; Walter A Med Pediatr Oncol; 1995 Jan; 24(1):61-2. PubMed ID: 7968797 [TBL] [Abstract][Full Text] [Related]
2. Accidental intrathecal administration of vincristine. Shepherd DA; Steuber CP; Starling KA; Fernbach DJ Med Pediatr Oncol; 1978; 5(1):85-8. PubMed ID: 284172 [TBL] [Abstract][Full Text] [Related]
4. Vincristine-induced peripheral neuropathy and urinary bladder paralysis in a child with rhabdomyosarcoma. Citak EC; Oguz A; Karadeniz C; Karaoglan B; Tan MO; Okur V; Cansu A J Pediatr Hematol Oncol; 2008 Jan; 30(1):61-2. PubMed ID: 18176183 [TBL] [Abstract][Full Text] [Related]
5. Fatal myeloencephalopathy due to accidental intrathecal vincristin administration: a report of two cases. Dettmeyer R; Driever F; Becker A; Wiestler OD; Madea B Forensic Sci Int; 2001 Oct; 122(1):60-4. PubMed ID: 11587867 [TBL] [Abstract][Full Text] [Related]
6. Inadvertent intrathecal vincristine administration: a neurosurgical emergency. Case report. Qweider M; Gilsbach JM; Rohde V J Neurosurg Spine; 2007 Mar; 6(3):280-3. PubMed ID: 17355029 [TBL] [Abstract][Full Text] [Related]
7. Inadvertent intrathecal vincristine administration: report of a fatal case despite cerebrospinal fluid lavage and a review of the literature. Pongudom S; Chinthammitr Y J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S258-63. PubMed ID: 21721457 [TBL] [Abstract][Full Text] [Related]
8. Two Fatal Cases of Accidental Intrathecal Vincristine Administration: Learning from Death Events. Chotsampancharoen T; Sripornsawan P; Wongchanchailert M Chemotherapy; 2016; 61(2):108-10. PubMed ID: 26636546 [TBL] [Abstract][Full Text] [Related]
10. Fatal myeloencephalopathy due to intrathecal vincristine administration. al Fawaz IM Ann Trop Paediatr; 1992; 12(3):339-42. PubMed ID: 1280054 [TBL] [Abstract][Full Text] [Related]
11. Potential salvage therapy for inadvertent intrathecal administration of vincristine. Michelagnoli MP; Bailey CC; Wilson I; Livingston J; Kinsey SE Br J Haematol; 1997 Nov; 99(2):364-7. PubMed ID: 9375755 [TBL] [Abstract][Full Text] [Related]
15. Urologic consequences of myelodysplasia and other congenital abnormalities of the spinal cord. Selzman AA; Elder JS; Mapstone TB Urol Clin North Am; 1993 Aug; 20(3):485-504. PubMed ID: 8351774 [TBL] [Abstract][Full Text] [Related]
16. Simple method to eliminate the risk of inadvertent intrathecal vincristine administration. Stefanou A; Dooley M J Clin Oncol; 2003 May; 21(10):2044; author reply 244. PubMed ID: 12743160 [No Abstract] [Full Text] [Related]
17. Inadvertent intrathecal administration of vincristine: has anything changed? Gilbar P J Oncol Pharm Pract; 2012 Mar; 18(1):155-7. PubMed ID: 21965437 [No Abstract] [Full Text] [Related]
18. Preventing vincristine administration errors: Does evidence support minibag infusions? Schulmeister L Clin J Oncol Nurs; 2006 Apr; 10(2):271-3. PubMed ID: 16708708 [TBL] [Abstract][Full Text] [Related]
19. Neural toxicity induced by accidental intrathecal vincristine administration. Kwack EK; Kim DJ; Park TI; Cho KR; Kwon IH; Sohn YK J Korean Med Sci; 1999 Dec; 14(6):688-92. PubMed ID: 10642952 [TBL] [Abstract][Full Text] [Related]
20. Prevent inadvertent administration of intrathecal vincristine. Eisenberg S ONS Connect; 2009 Jan; 24(1):22. PubMed ID: 19253477 [No Abstract] [Full Text] [Related] [Next] [New Search]